Please enable JavaScript to continue using this application.

Compare $DTIL vs $WHWK | Chartloom

Compare

$DTIL vs $WHWK

Precision BioSciences Inc · Whitehawk Therapeutics Inc

DTIL

Precision BioSciences Inc

WHWK

Whitehawk Therapeutics Inc

Compare $DTIL vs $WHWK

Comparing Precision BioSciences Inc and Whitehawk Therapeutics Inc

DTILPrecision BioSciences Inc

WHWKWhitehawk Therapeutics Inc

DTILPrecision BioSciences Inc

Market cap

$173M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

80.94x

Rev growth (TTM)

3473.0%

YTD performance

63.9%

52W performance

17.9%

FCF yield

-30.2%

WHWKWhitehawk Therapeutics Inc

Market cap

$189M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

44.3%

52W performance

65.3%

FCF yield

-36.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DTIL

WHWK

Detailed metrics comparison

DTIL

Precision BioSciences Inc

WHWK

Whitehawk Therapeutics Inc

Market Cap

DTIL$173M

WHWK$189M

Enterprise Value

DTIL$110M

WHWK$104M

Price

DTIL$6.72

WHWK$3.52

P/E Ratio

DTILN/A

WHWKN/A

P/S Ratio

DTIL3.85x

WHWK7.56x

EV/Sales

DTIL2.44x

WHWK0.00x

EV/EBITDA

DTIL0.00x

WHWK0.00x

P/B Ratio

DTIL3.85x

WHWK1.15x

P/FCF Ratio

DTILN/A

WHWKN/A

EV/FCF

DTIL-2.09x

WHWK-1.50x

PEG Ratio

DTILN/A

WHWKN/A

Forward P/E (NTM)

DTILN/A

WHWKN/A

Forward P/S (NTM)

DTIL80.94x

WHWKN/A

Revenue (TTM)

DTIL$45M

WHWK$0

Revenue Growth (YoY)

DTIL3473.0%

WHWK-100.0%

Forward Rev Growth

DTIL-28.2%

WHWK167.6%

Gross Margin (TTM)

DTIL0.0%

WHWK88.7%

Operating Margin (TTM)

DTIL0.0%

WHWK87.4%

EBITDA Margin (TTM)

DTIL-78.0%

WHWK0.0%

Net Margin (TTM)

DTIL-117.0%

WHWK99.4%

FCF Margin (TTM)

DTIL-116.3%

WHWKN/A

Net Income (TTM)

DTIL$-53M

WHWK$-80M

FCF (TTM)

DTIL$-52M

WHWK$-69M

EPS (TTM)

DTIL-$2.04

WHWK-$0.96

ROE (TTM)

DTIL-9160.0%

WHWK-5389.0%

ROA (TTM)

DTIL-4074.0%

WHWK-4997.0%

ROIC (TTM)

DTIL-6594.0%

WHWK-5389.0%

Cash

DTIL$86M

WHWK$85M

Debt

DTIL$22M

WHWK$0

Net Cash/Debt

DTIL$64M

WHWK$85M

Current Ratio (TTM)

DTIL12.82x

WHWK17.38x

Quick Ratio (TTM)

DTIL12.26x

WHWK17.16x

Debt/Equity (TTM)

DTIL0.50x

WHWK0.00x

Debt/Assets (TTM)

DTIL0.0%

WHWK0.0%

Interest Coverage (TTM)

DTILN/A

WHWKN/A

Net Debt/EBITDA (TTM)

DTIL0.00x

WHWK0.00x

Beta

DTIL1.44

WHWK0.99

52W Performance

DTIL17.9%

WHWK65.3%

YTD Performance

DTIL63.9%

WHWK44.3%

% from 52W High

DTIL-30.1%

WHWK-35.9%

% from 52W Low

DTIL90.4%

WHWK88.2%

Asset Turnover (TTM)

DTIL0.36x

WHWK0.23x

FCF Yield (TTM)

DTIL-30.2%

WHWK-36.6%

Earnings Yield (TTM)

DTIL-30.4%

WHWK-42.2%

Dividend Yield (TTM)

DTILN/A

WHWKN/A

Rule of 40

DTIL3,356.7

WHWK-100.0

EV/GP/RG

DTILN/A

WHWKN/A

Ticker research

View DTIL research View WHWK research

Metric	DTIL Precision BioSciences Inc	WHWK Whitehawk Therapeutics Inc
Market & Valuation
Market Cap	$173M	$189M
Enterprise Value	$110M	$104M
Price	$6.72	$3.52
P/E Ratio	N/A	N/A
P/S Ratio	3.85x	7.56x
EV/Sales	2.44x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.85x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.09x	-1.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	80.94x	N/A
Revenue & Growth
Revenue (TTM)	$45M	$0
Revenue Growth (YoY)	3473.0%	-100.0%
Forward Rev Growth	-28.2%	167.6%
Profitability
Gross Margin (TTM)	0.0%	88.7%
Operating Margin (TTM)	0.0%	87.4%
EBITDA Margin (TTM)	-78.0%	0.0%
Net Margin (TTM)	-117.0%	99.4%
FCF Margin (TTM)	-116.3%	N/A
Net Income (TTM)	$-53M	$-80M
FCF (TTM)	$-52M	$-69M
EPS (TTM)	-$2.04	-$0.96
ROE (TTM)	-9160.0%	-5389.0%
ROA (TTM)	-4074.0%	-4997.0%
ROIC (TTM)	-6594.0%	-5389.0%
Financial Health
Cash	$86M	$85M
Debt	$22M	$0
Net Cash/Debt	$64M	$85M
Current Ratio (TTM)	12.82x	17.38x
Quick Ratio (TTM)	12.26x	17.16x
Debt/Equity (TTM)	0.50x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.44	0.99
52W Performance	17.9%	65.3%
YTD Performance	63.9%	44.3%
% from 52W High	-30.1%	-35.9%
% from 52W Low	90.4%	88.2%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.23x
FCF Yield (TTM)	-30.2%	-36.6%
Earnings Yield (TTM)	-30.4%	-42.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3,356.7	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View DTIL research	View WHWK research

Valuation

P/S Ratio

DTIL

3.85x

WHWK

7.56x

EV/FCF

DTIL

-2.09x

WHWK

-1.50x

Growth & revenue

Revenue Growth TTM

DTIL

3473.0%

WHWK

-100.0%

Forward Revenue Growth

WHWK

167.6%

DTIL

-28.2%

Profitability & performance

Gross Margin

WHWK

88.7%

DTIL

0.0%

ROE

WHWK

-5389.0%

DTIL

-9160.0%

FCF Yield %

DTIL

-30.2%

WHWK

-36.6%

52-Week Performance

WHWK

65.3%

DTIL

17.9%

Detailed metrics comparison

DTIL

Precision BioSciences Inc

WHWK

Whitehawk Therapeutics Inc

Market Cap

DTIL$173M

WHWK$189M

Enterprise Value

DTIL$110M

WHWK$104M

Price

DTIL$6.72

WHWK$3.52

P/E Ratio

DTILN/A

WHWKN/A

P/S Ratio

DTIL3.85x

WHWK7.56x

EV/Sales

DTIL2.44x

WHWK0.00x

EV/EBITDA

DTIL0.00x

WHWK0.00x

P/B Ratio

DTIL3.85x

WHWK1.15x

P/FCF Ratio

DTILN/A

WHWKN/A

EV/FCF

DTIL-2.09x

WHWK-1.50x

PEG Ratio

DTILN/A

WHWKN/A

Forward P/E (NTM)

DTILN/A

WHWKN/A

Forward P/S (NTM)

DTIL80.94x

WHWKN/A

Revenue (TTM)

DTIL$45M

WHWK$0

Revenue Growth (YoY)

DTIL3473.0%

WHWK-100.0%

Forward Rev Growth

DTIL-28.2%

WHWK167.6%

Gross Margin (TTM)

DTIL0.0%

WHWK88.7%

Operating Margin (TTM)

DTIL0.0%

WHWK87.4%

EBITDA Margin (TTM)

DTIL-78.0%

WHWK0.0%

Net Margin (TTM)

DTIL-117.0%

WHWK99.4%

FCF Margin (TTM)

DTIL-116.3%

WHWKN/A

Net Income (TTM)

DTIL$-53M

WHWK$-80M

FCF (TTM)

DTIL$-52M

WHWK$-69M

EPS (TTM)

DTIL-$2.04

WHWK-$0.96

ROE (TTM)

DTIL-9160.0%

WHWK-5389.0%

ROA (TTM)

DTIL-4074.0%

WHWK-4997.0%

ROIC (TTM)

DTIL-6594.0%

WHWK-5389.0%

Cash

DTIL$86M

WHWK$85M

Debt

DTIL$22M

WHWK$0

Net Cash/Debt

DTIL$64M

WHWK$85M

Current Ratio (TTM)

DTIL12.82x

WHWK17.38x

Quick Ratio (TTM)

DTIL12.26x

WHWK17.16x

Debt/Equity (TTM)

DTIL0.50x

WHWK0.00x

Debt/Assets (TTM)

DTIL0.0%

WHWK0.0%

Interest Coverage (TTM)

DTILN/A

WHWKN/A

Net Debt/EBITDA (TTM)

DTIL0.00x

WHWK0.00x

Beta

DTIL1.44

WHWK0.99

52W Performance

DTIL17.9%

WHWK65.3%

YTD Performance

DTIL63.9%

WHWK44.3%

% from 52W High

DTIL-30.1%

WHWK-35.9%

% from 52W Low

DTIL90.4%

WHWK88.2%

Asset Turnover (TTM)

DTIL0.36x

WHWK0.23x

FCF Yield (TTM)

DTIL-30.2%

WHWK-36.6%

Earnings Yield (TTM)

DTIL-30.4%

WHWK-42.2%

Dividend Yield (TTM)

DTILN/A

WHWKN/A

Rule of 40

DTIL3,356.7

WHWK-100.0

EV/GP/RG

DTILN/A

WHWKN/A

Ticker research

View DTIL research View WHWK research

Metric	DTIL Precision BioSciences Inc	WHWK Whitehawk Therapeutics Inc
Market & Valuation
Market Cap	$173M	$189M
Enterprise Value	$110M	$104M
Price	$6.72	$3.52
P/E Ratio	N/A	N/A
P/S Ratio	3.85x	7.56x
EV/Sales	2.44x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.85x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.09x	-1.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	80.94x	N/A
Revenue & Growth
Revenue (TTM)	$45M	$0
Revenue Growth (YoY)	3473.0%	-100.0%
Forward Rev Growth	-28.2%	167.6%
Profitability
Gross Margin (TTM)	0.0%	88.7%
Operating Margin (TTM)	0.0%	87.4%
EBITDA Margin (TTM)	-78.0%	0.0%
Net Margin (TTM)	-117.0%	99.4%
FCF Margin (TTM)	-116.3%	N/A
Net Income (TTM)	$-53M	$-80M
FCF (TTM)	$-52M	$-69M
EPS (TTM)	-$2.04	-$0.96
ROE (TTM)	-9160.0%	-5389.0%
ROA (TTM)	-4074.0%	-4997.0%
ROIC (TTM)	-6594.0%	-5389.0%
Financial Health
Cash	$86M	$85M
Debt	$22M	$0
Net Cash/Debt	$64M	$85M
Current Ratio (TTM)	12.82x	17.38x
Quick Ratio (TTM)	12.26x	17.16x
Debt/Equity (TTM)	0.50x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.44	0.99
52W Performance	17.9%	65.3%
YTD Performance	63.9%	44.3%
% from 52W High	-30.1%	-35.9%
% from 52W Low	90.4%	88.2%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.23x
FCF Yield (TTM)	-30.2%	-36.6%
Earnings Yield (TTM)	-30.4%	-42.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3,356.7	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View DTIL research	View WHWK research